A 2006 Achilles-detachment study by Krivic and colleagues in the same journal applied BPC-157 intraperitoneally once daily at 10 g/kg, 10 ng/kg, or 10 pg/kg for 30 days in rats and reported that tendon-to-bone tissue, which did not heal spontaneously in saline controls, recovered with BPC-157 treatment, with directionally improved load-to-failure, stiffness, Young's modulus, and collagen organization at days 121, including in animals where healing had been impaired by 1 mg/kg 6-methylprednisolone though the abstract does not report numeric effect sizes or p-values
Some protocols suggest taking KPV in the morning for optimal absorption, while others divide the dose between morning and evening
Some suppliers may require additional documentation for international shipping
Key points highlighted in the session included: GLP-1 receptor agonists have been used clinically since 2005, with earlier formulations prescribed at lower doses Newer medications and dosing regimens have increased weight loss outcomes Public familiarity with medications such as Ozempic, Wegovy, Mounjaro, and Zepbound has grown rapidly Increased access and demand have led to broader prescribing patterns and new clinical questions This growth has outpaced many clinicians training around eating disorder risk and weight-inclusive care
As a potent detoxifier of the liver, Glutathione is often combined with Vitamin C to enhance antioxidant and detox benefits, neutralize free radicals, and promote skin whitening
FDA-approved for weight management (Zepbound) and type 2 diabetes (Mounjaro)
